Delivery Order SPE2DB22D1002-SPE2DB25FLAR6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units, with a ceiling value of $8,195.85. This competitively awarded, firm fixed-price delivery order was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $39,912.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on September 12, 2025, with completion targeted for September 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewables in unit dose packaging, with a contract value of $3,330.33 and an ultimate completion date of October 23, 2025. This firm fixed-price delivery order, awarded on October 22, 2025, was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,492.00 to AmerisourceBergen Drug Corp for the supply of Emverm 100 mg tablet chewables under contract 4568864711. This firm fixed-price delivery order, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $7,266.59. This competitively awarded, firm fixed-price delivery order is set to conclude by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition based on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packaging, with a ceiling value of $1,559.56. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,317.21 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units under delivery order contract 4569293882. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will be conducted at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,190.41 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded delivery order represents a single-item pharmaceutical procurement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Emverm 100 mg tablet chewables in unit dose packages. This competitively awarded, non-set-aside contract carries a ceiling value of $8,063.38 under a firm fixed-price delivery order model, with an ultimate completion date of December 17, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of single dose, valued at $17,223.18 under a firm fixed price contract type. This non-set-aside award was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLAR6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of use (UDS) on April 10, 2025, with a ceiling value of $3,423.88. This firm fixed-price delivery order, with an ultimate completion date of April 11, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for a comprehensive range of pharmaceutical products supporting military and veteran healthcare systems. The DLA Troop Support Medical IDC serves as a global pharmaceutical support vehicle enabling the company to supply brand-name and generic drugs, specialty medications, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare customers. This delivery order for Emverm exemplifies the company's role as a primary pharmaceutical supplier within the broader federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 4/10/25 |